← Back to all trials
Completed
NCT04512118
CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 Patients
Conditions: Presence of COVID-19 Compatible CT Abnormalities
Sex: All
Ages: 18 Years – N/A
Enrollment: 22
Sponsor: Central Hospital, Nancy, France
Location: CHRU of Nancy Vandœuvre-lès-Nancy Grand Est
Summary
CT signs that are evocative of lung COVID-19 infections have been extensively described, whereas 18F-FDG-PET signs have not. Our current study aimed to identify specific COVID-19 18F-FDG-PET signs in patients that were (i) suspected to have a lung infection based on 18F-FDG-PET/CT recorded during the COVID-19 outbreak and (ii) whose COVID-19 diagnosis was definitely established or excluded by appropriate viral testing.
Eligibility Criteria
Inclusion Criteria:
* Patient coming to nuclear medicine for 18F-flurodesoxyglucose (FDG) positron emission tomography computed tomography (PET-CT) with suspicion of lung involvement
* patient affiliated to a social security scheme or equivalent
* adult patient having been informed of the study
Exclusion Criteria:
* patient with a negative covid 19 test
Source: ClinicalTrials.gov (NCT04512118). StuddyBuddy aggregates publicly available trial information.